Follicum’s diabetes project with Lund University has been awarded a Post-Doc student for 2 years for advanced studies of Follicum’s peptides
Follicum AB ("Follicum" or "Company"), a biotech company developing new peptide drugs in two areas, hair loss and diabetes, today reports that a full-time post-doc has been awarded to the diabetes project for 2 years. The aim with the project is to perform advanced experiments to further investigate the action of Follicum’s different peptide classes. The post-doc will be 100% financed by the LUDC-IRC consortium.As previously reported Follicum is part of a large collaborative diabetes network called LUDC-IRC at Lund University. The consortium has received 100 million SEK from The Swedish